Cite
HARVARD Citation
Gertz, M. et al. (2021). Should high risk smoldering myeloma be treated outside a clinical trial: NO. Leukemia & lymphoma. 62 (11), pp. 2565-2567. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gertz, M. et al. (2021). Should high risk smoldering myeloma be treated outside a clinical trial: NO. Leukemia & lymphoma. 62 (11), pp. 2565-2567. [Online].